"Our strategy has always been to “partner” PeriCoach™ with one or more suitable multinational medical device / consumer goods companies. " So what was the strategy for the burette??? !!! Leave it on the shelf until the patent expires?
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025